The Enterprise Value as of October 2024 (TTM) for IDEAYA Biosciences, Inc. (IDYA) is 2.41B

According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.41B. This represents a change of 3.24% compared to the average of 2.34B of the last 4 quarters.

IDEAYA Biosciences, Inc. (IDYA) Historical Enterprise Value (quarterly & annually)

How has IDYA Enterprise Value performed in the past?

The mean historical Enterprise Value of IDEAYA Biosciences, Inc. over the last ten years is 575.36M. The current 2.41B Enterprise Value has changed 41.81% with respect to the historical average. Over the past ten years (40 quarters), IDYA's Enterprise Value was at its highest in in the March 2024 quarter at 3.09B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

IDEAYA Biosciences, Inc. (IDYA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IDEAYA Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IDEAYA Biosciences, Inc. (IDYA) Average Enterprise Value

How has IDYA Enterprise Value performed in the past?

The current Enterprise Value of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IDEAYA Biosciences, Inc. (IDYA) Enterprise Value vs. Peers

How is IDYA’s Enterprise Value compared to its peers?

IDEAYA Biosciences, Inc.’s Enterprise Value is greater than AnaptysBio, Inc. (1.37B), greater than MeiraGTx Holdings plc (447.34M), greater than Keros Therapeutics, Inc. (1.90B), greater than Homology Medicines, Inc. (-103303255.00), greater than Ventyx Biosciences, Inc. (143.48M), less than Protagonist Therapeutics, Inc. (2.43B), less than Verona Pharma plc (2.62B), greater than Syndax Pharmaceuticals, Inc. (1.59B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Avidity Biosciences, Inc. (5.12B), less than Revolution Medicines, Inc. (8.16B), greater than Day One Biopharmaceuticals, Inc. (1.08B), greater than SpringWorks Therapeutics, Inc. (2.21B), greater than Terns Pharmaceuticals, Inc. (542.02M), greater than Acumen Pharmaceuticals, Inc. (120.07M), greater than Amylyx Pharmaceuticals, Inc. (195.03M), less than MoonLake Immunotherapeutics (2.68B), greater than X4 Pharmaceuticals, Inc. (14.70M), greater than Inozyme Pharma, Inc. (354.56M), greater than VectivBio Holding AG (848.58M),

Build a custom stock screener for IDEAYA Biosciences, Inc. (IDYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IDEAYA Biosciences, Inc. (IDYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.